News & Events

OneOme Expands its Comprehensive Pharmacogenomic Test Offering with New Genes and Medications

MINNEAPOLIS (MAY 22, 2018) — OneOme, co-developed by Mayo Clinic, today announced several significant enhancements to its product offering, including the addition of four new genes (HLA-A, HLA-B, CYP4F2, and CYP2C Cluster) and nine new medications to its RightMed® comprehensive test, a pharmacoge...


OneOme Named One of the World’s 50 Most Innovative Companies for 2018 by Fast Company

MINNEAPOLIS (February 20, 2018) – OneOme, a healthcare technology company whose genetic test helps predict how a person will respond to hundreds of medications and enables healthcare providers to prescribe more effective medications, today announced that it is included in Fast Company’s annual r...


Patients Can Now Request a OneOme RightMed® Test Through an Independent Provider Network

MINNEAPOLIS (January 10, 2018) – Precision medicine company OneOme is partnering with PWNHealth to increase patient access to the RightMed® comprehensive test without compromising patient safety.

Until now, patients interested in the RightMed test could only get it by talking to their doctor. Th...


OneOme Wins 2017 Tekne Award in Healthcare

MHTA Award Recognizes Company’s Innovation and Leadership

MINNEAPOLIS (November 16, 2017) – Last night, OneOme was awarded a Tekne Award in Healthcare at the 18th Annual Minnesota High Tech Association (MHTA) Tekne Awards. The Tekne Awards honor companies and individuals in Minnesota who have demonstrated superior technology innovation and leadership. On...


Concierge Medicine Forum Features OneOme Expert on Pharmacogenomics

Precision Medicine Company Aims to Make Prescriptions Personal

MINNEAPOLIS (October 26, 2017) – The Concierge Medicine Forum held this week in Atlanta will feature an expert on pharmacogenomics from OneOme, a leading precision medicine company. Ryan Gregg, Ph.D, medical science liaison from OneOme, will present a session on pharmacogenomics on Friday, Octob...